Waldencast plc (MLKMF)
OTCMKTS · Delayed Price · Currency is USD
0.888199
+0.038199 (4.49%)
At close: Oct 16, 2026
Waldencast Revenue
Waldencast had revenue of $66.14M in the half year ending June 30, 2025, with 0.53% growth. This brings the company's revenue in the last twelve months to $274.56M, up 14.22% year-over-year. In the year 2024, Waldencast had annual revenue of $273.87M with 25.55% growth. That makes Waldencast the 16,182nd largest company in the world by revenue and 2,774th in the United States.
Revenue (ttm)
274.56M
Revenue Growth
+14.22%
P/S Ratio
0.45
Revenue / Employee
646.63K
Employees
367
Market Cap
106.03M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 273.87M | 55.73M | 25.55% |
| Dec 31, 2023 | 218.14M | 125.77M | 136.15% |
| Dec 31, 2022 | 92.37M | -113.70M | -55.17% |
| Dec 31, 2021 | 206.07M | 111.64M | 118.23% |
| Dec 31, 2020 | 94.43M | -22.66M | -19.35% |
| Dec 31, 2019 | 117.09M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| The Stephan Co. | 15.66M |
| CCA Industries | 7.74M |
| Adapti | 3.66M |
| PURE Bioscience | 2.42M |
| DSwiss | 1.89M |
| Skinvisible | 20.00K |
| Bemax | 6.38K |
Waldencast News
- 2 days ago - Waldencast plc Files Form 15 to Deregister its Securities and Suspend its SEC Reporting Obligations under the Exchange Act - GlobeNewsWire
- 19 days ago - Waldencast plc Announces First Half 2026 Financial Results - GlobeNewsWire
- 19 days ago - Waldencast Earnings release: Q2 2026 - Filings
- 23 days ago - Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act - GlobeNewsWire
- 4 weeks ago - Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act - GlobeNewsWire
- 2 months ago - Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint - GlobeNewsWire
- 4 months ago - Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel - GlobeNewsWire
- 4 months ago - Waldencast Announces Sale of Obagi Medical to Bridgepoint - GlobeNewsWire